Community-reported Copaxone side effects:
copaxone herpes zooster 2008-11-07 14:55:57
Add Your Side Effect to the Community Database
Help Community - Describe Your Copaxone Side Effect
Have You dealt with a Copaxone side effect? Share your experience
Review Copaxone Safety Reports submitted to FDA
Total Copaxone reports: 397.Copaxone FDA safety alerts: No.
Reported deaths: 25 Reported hospitalizations: 206.
Take Copaxone Side Effects Survey, Discuss Copaxone with others
FDA Reported Copaxone Side Effects: multiple sclerosis relapse, hypersensitivity, dyspnoea, convulsion, anaphylactic reaction, pyrexia, urticaria, loss of consciousness, cerebrovascular accident, vomiting, pain in extremity.
Copaxone Usage.
If you have questions about Copaxone, you can ask a Health Expert or Ask Patient Community about Copaxone.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
< Previous Showing 301-397 of 397
Copaxone Side Effects Report #5379546-8Physician from UNITED STATES reported COPAXONE problem on June 22, 2007. Male patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: pyrexia, renal failure, thrombocytopenic purpura. COPAXONE dosage: 20 MG, SUBCUTANEOUS. During the same period patient was treated with FOLATE, PREDNISONE. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5379547-X
COPAXONE problem was reported by a Physician from UNITED STATES on June 22, 2007. Male patient, 39 years of age, weighting 272.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: actinomycotic skin infection, bone disorder, bronchitis chronic, jaw disorder, lymphoma, pain in jaw, purulent discharge, staphylococcal infection, swelling. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. During the same period patient was treated with AMANTADINE, CETIRIZINE HYDROCHLORIDE, LAMOTRIGINE, FENOPROFEN CALCIUM, BACLOFEN, COMBIVENT, SALBUTAMOL, DOXYCYCLINE. Patient recovered.
Copaxone Side Effects Report #5382654-9
Pharmacist from UNITED STATES reported COPAXONE problem on July 03, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: urticaria. COPAXONE dosage: 20MG QD SQ. Patient recovered.
Copaxone Side Effects Report #5382869-X
COPAXONE problem was reported by a Health Professional from UNITED STATES on July 03, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, injection site erythema. COPAXONE dosage: COPAXONE 20MG DAILY SQ. Patient recovered.
Copaxone Side Effects Report #5383042-1
Consumer or non-health professional from GERMANY reported COPAXONE problem on June 28, 2007. Female patient, 39 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: guillain-barre syndrome, multiple sclerosis relapse. COPAXONE dosage: 20 MG (20 MG , 1 IN 1 D). Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5386004-3
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on June 27, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin m increased, cell-mediated immune deficiency, herpes simplex, thrombocytopenia, vaginal candidiasis. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5387147-0
Health Professional from UNITED STATES reported COPAXONE problem on July 02, 2007. Female patient, 30 years of age, weighting 233.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: embolism, fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, thromboangiitis obliterans, vasculitis, white blood cell count increased. COPAXONE dosage: (20 MG), SUBCUTANEOUS. During the same period patient was treated with NIFEDIPINE, DYAZIDE, LISINOPRIL, LABETALOL, NAPROXEN, VICODIN. Patient recovered.
Copaxone Side Effects Report #5388663-8
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on July 03, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cell-mediated immune deficiency, herpes simplex, herpes zoster, hyper igm syndrome, idiopathic thrombocytopenic purpura, vaginal candidiasis. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5390946-2
Health Professional from UNITED STATES reported COPAXONE problem on July 03, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: treatment noncompliance, tuberculosis. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5392971-4
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, diarrhoea, gangrene, intestinal gangrene, neoplasm malignant, renal failure, white blood cell count increased. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5393069-1
Consumer or non-health professional from AUSTRIA reported COPAXONE problem on July 05, 2007. Female patient, 34 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: malignant melanoma. COPAXONE dosage: (20 MG); SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5394595-1
COPAXONE problem was reported by a Physician from UNITED STATES on July 09, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: dementia. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5394602-6
Pharmacist from UNITED STATES reported COPAXONE problem on July 09, 2007. Female patient, 35 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: intestinal ischaemia. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5758448-9
COPAXONE problem was reported by a Pharmacist from UNITED STATES on May 28, 2008. Female patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, jaundice, oedema. COPAXONE dosage: unknown. During the same period patient was treated with BACLOFEN, NAPROXEN, TIZANIDINE. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5762662-6
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on June 04, 2008. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: pyrexia, respiratory arrest, vomiting. COPAXONE dosage: unknown. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5763812-8
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2008. Male patient, weighting 175.0 lb, was diagnosed with muscular weakness and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: fall, gait disturbance, movement disorder, muscular weakness. COPAXONE dosage: unknown. During the same period patient was treated with TRAMADOL, METHYLPREDNISOLONE. Patient recovered.
Copaxone Side Effects Report #5763917-1
Health Professional from UNITED STATES reported COPAXONE problem on June 06, 2008. Female patient, 34 years of age, weighting 175.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: chills, convulsion, dyspnoea, flushing. COPAXONE dosage: 20 ML EVERY DAY SQ. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5766596-2
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 10, 2008. Female patient, 58 years of age, weighting 160.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: asthenia, back pain, chest discomfort, immobile, muscle tightness, myalgia, pain in extremity, skin warm. COPAXONE dosage: unknown. Patient recovered.
Copaxone Side Effects Report #5771519-6
Health Professional from UNITED STATES reported COPAXONE problem on June 12, 2008. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: abasia, back pain, cough, crying, depression, dyspnoea, exercise tolerance decreased, fatigue, haemorrhagic diathesis. COPAXONE dosage: 20MG QD SQ. During the same period patient was treated with AMANTADINE, PROVIGIL, PROZAC, XANAX, MECLAZENE, PERCOCET. Patient recovered.
Copaxone Side Effects Report #5787123-X
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2008. Female patient, weighting 122.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: bronchial disorder, ear pain, fatigue, headache, insomnia, lymphadenopathy, mental disability, pharyngolaryngeal pain, pyrexia. COPAXONE dosage: 20MG DAILY SQ. Patient recovered.
Copaxone Side Effects Report #5787149-6
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on June 23, 2008. Female patient, 42 years of age, weighting 135.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: lipoatrophy, treatment noncompliance. COPAXONE dosage: 1 ML 1 PER DAY SQ. Patient recovered.
Copaxone Side Effects Report #5787843-7
COPAXONE problem was reported by a Health Professional from UNITED STATES on June 24, 2008. Female patient, 43 years of age, weighting 220.0 lb, was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cough, dizziness, nausea, pain in extremity, palpitations. COPAXONE dosage: 20 MG DAILY SQ. Patient recovered.
Copaxone Side Effects Report #5793072-3
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on June 26, 2008. Female patient, 29 years of age, weighting 115.0 lb, was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: pharyngeal oedema, urticaria. COPAXONE dosage: unknown. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5794890-8
COPAXONE problem was reported by a Health Professional from UNITED STATES on June 27, 2008. Female patient was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. COPAXONE dosage: 20 MG SUB-Q DAILY SQ. Patient recovered.
Copaxone Side Effects Report #5730678-1
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on May 06, 2008. Male patient, 52 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: convulsion, hypersensitivity, pulmonary embolism. COPAXONE dosage: unknown. Patient was hospitalized. Patient died on 07/12/2007.
Copaxone Side Effects Report #5731417-0
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on May 06, 2008. Female patient, 25 years of age, was diagnosed with dyspnoea and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. COPAXONE dosage: unknown. Patient recovered.
Copaxone Side Effects Report #5750272-6
Pharmacist from UNITED STATES reported COPAXONE problem on May 22, 2008. Female patient was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, chest discomfort, menstrual disorder. COPAXONE dosage: 20MG QD S.Q.. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5759340-6
COPAXONE problem was reported by a Consumer or non-health professional from CANADA on May 19, 2008. Female patient, 41 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: aspiration, brain oedema, coma, disorientation, dysarthria, pneumonitis, pupil fixed, renal failure. COPAXONE dosage: unknown. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, SERTRALINE, BACLOFEN, METHYLPHENIDATE, ZALEPLON, PREDNISONE, TOLTERODINE TARTRATE. Patient died.
Copaxone Side Effects Report #5695632-7
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on Apr 01, 2008. Female patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: faecal incontinence, feeling hot, flushing, loss of consciousness, vomiting. COPAXONE dosage: unknown. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5695633-9
COPAXONE problem was reported by a Physician from UNITED STATES on Apr 01, 2008. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: anaplastic large cell lymphoma t- and null-cell types. COPAXONE dosage: unknown. Patient recovered.
Copaxone Side Effects Report #5699574-2
Physician from BELGIUM reported COPAXONE problem on Mar 29, 2008. Female patient, 60 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic. COPAXONE dosage: unknown. During the same period patient was treated with CORTISONE. Patient recovered.
Copaxone Side Effects Report #5723512-7
COPAXONE problem was reported by a Health Professional from FRANCE on Apr 24, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: injection site pain, monoplegia. COPAXONE dosage: unknown. Patient recovered.
Copaxone Side Effects Report #5353163-8
Consumer or non-health professional from SPAIN reported COPAXONE problem on May 23, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: raynaud's phenomenon. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D). Patient recovered.
Copaxone Side Effects Report #5353164-X
COPAXONE problem was reported by a Consumer or non-health professional from AUSTRIA on May 25, 2007. Female patient, 34 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: malignant melanoma. COPAXONE dosage: 20 MG. Patient recovered.
Copaxone Side Effects Report #5357003-2
Pharmacist from UNITED STATES reported COPAXONE problem on June 12, 2007. Female patient, weighting 130.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral. COPAXONE dosage: 20MG DAILY SUB-Q. Patient recovered.
Copaxone Side Effects Report #5357399-1
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on May 30, 2007. Female patient, 39 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: guillain-barre syndrome. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5361079-6
Physician from UNITED STATES reported COPAXONE problem on June 01, 2007. Female patient, 38 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, coronary artery disease, liver function test abnormal. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5361080-2
COPAXONE problem was reported by a Physician from UNITED STATES on June 01, 2007. Female patient, 30 years of age, weighting 233.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, peripheral embolism, peripheral ischaemia, peripheral vascular disorder, white blood cell count increased. COPAXONE dosage: 20 MG, SUBCUTANEOUS. During the same period patient was treated with NIFEDIPINE, DYAZIDE, LISINOPRIL, LABETALOL, NAPROXEN, VICODIN. Patient recovered.
Copaxone Side Effects Report #5363030-1
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on June 04, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, coronary artery bypass, diabetes mellitus. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient died on 03/22/2007.
Copaxone Side Effects Report #5363031-3
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5363040-4
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on June 11, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: megacolon, volvulus. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5365794-X
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, large intestine perforation. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5366204-9
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on June 04, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5367427-5
COPAXONE problem was reported by a Pharmacist from UNITED STATES on June 20, 2007. Female patient, 43 years of age, weighting 203.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: aphasia, dry throat, flushing, injection site erythema, injection site pain, injection site swelling, injection site urticaria, muscle spasms. COPAXONE dosage: 20 MG SQ DAILY 10MG BID SQ BID. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5369949-X
Pharmacist from GERMANY reported COPAXONE problem on June 06, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin m increased, cell-mediated immune deficiency, herpes zoster, idiopathic thrombocytopenic purpura, vaginal candidiasis. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D); SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5372545-1
COPAXONE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 13, 2007. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, dysphasia, encephalitis, unresponsive to stimuli. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. Patient was hospitalized and became disabled. Patient recovered.
Copaxone Side Effects Report #5372546-3
Consumer or non-health professional from GERMANY reported COPAXONE problem on June 15, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cystosarcoma phyllodes. COPAXONE dosage: 20 MG (20 MG, ONCE A DAY). During the same period patient was treated with POTASSIUM IODIDE, ARIPIPRAZOLE. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5373327-7
COPAXONE problem was reported by a Pharmacist from UNITED STATES on June 26, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blister, furuncle, hypersensitivity, swelling. COPAXONE dosage: 20MG QD SQ. Patient recovered.
Copaxone Side Effects Report #5317810-9
Physician from UNITED STATES reported COPAXONE problem on May 02, 2007. Male patient, 58 years of age, weighting 250.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cellulitis, eschar, injection site erythema, necrosis, skin lesion. COPAXONE dosage: 20 MG QD SQ. During the same period patient was treated with COUMADIN. Patient recovered.
Copaxone Side Effects Report #5324342-0
COPAXONE problem was reported by a Consumer or non-health professional from FRANCE on Apr 26, 2007. Female patient, 62 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, inflammation, injection site erythema, red blood cell sedimentation rate increased. COPAXONE dosage: 20 MG (20 MG, 1 IN1 D); SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5325779-6
Consumer or non-health professional from GERMANY reported COPAXONE problem on Apr 30, 2007. Male patient, 38 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5325781-4
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on Apr 27, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: guillain-barre syndrome, paraesthesia, paraesthesia oral. COPAXONE dosage: 20 MG (10 MG, 1 IN 1 D) , SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5326140-0
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on Apr 26, 2007. Male patient was diagnosed with multiple sclerosis and was treated with COPAXONE. COPAXONE dosage: 20 MG;SUBCUTANEOUS. Patient died.
Copaxone Side Effects Report #5326145-X
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: toxic shock syndrome. COPAXONE dosage: 20MG; SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5326165-5
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on May 03, 2007. Female patient, 62 years of age, was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: haemorrhage. COPAXONE dosage: unknown. Patient recovered.
Copaxone Side Effects Report #5326863-3
COPAXONE problem was reported by a Consumer or non-health professional from FRANCE on Apr 30, 2007. Female patient, 31 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, hyperglycaemia. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D). During the same period patient was treated with INSULIN, INSULIN ASPART, INSUMAN COMB. Patient recovered.
Copaxone Side Effects Report #5327310-8
Pharmacist from UNITED STATES reported COPAXONE problem on May 01, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, sarcoidosis. COPAXONE dosage: (20 MG), SUBCUTANEOUS. During the same period patient was treated with VITAMIN CAP, FLUOXETINE HYDROCHLORIDE. Patient recovered.
Copaxone Side Effects Report #5331002-9
COPAXONE problem was reported by a Health Professional from UNITED STATES on May 18, 2007. Female patient, weighting 170.0 lb, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: back pain, chills, groin pain, muscular weakness, myalgia, pain in extremity, tremor. COPAXONE dosage: 20 MG DAILY SQ. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5331704-4
Physician from UNITED STATES reported COPAXONE problem on May 04, 2007. Female patient, 68 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: thyroid cancer. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5334405-1
COPAXONE problem was reported by a Health Professional from UNITED STATES on May 11, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. COPAXONE dosage: (20 MG), SUBCUTANEOUS. During the same period patient was treated with INTERFERON BETA. Patient died on 04/20/2007.
Copaxone Side Effects Report #5343419-7
Consumer or non-health professional from GERMANY reported COPAXONE problem on May 18, 2007. Male patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: follicle centre lymphoma, follicular grade i, ii, iii. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5343420-3
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on May 18, 2007. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: acoustic neuroma, hypoacusis, nystagmus. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5343733-5
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on May 18, 2007. Female patient was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5343734-7
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: accident, injury, lower limb fracture. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5343735-9
Physician from UNITED STATES reported COPAXONE problem on May 17, 2007. Male patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, pyrexia, thrombotic thrombocytopenic purpura. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5343929-2
COPAXONE problem was reported by a Physician from UNITED STATES on May 16, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: injection site mass, lymphoma. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5290233-7
Physician from UNITED STATES reported COPAXONE problem on Mar 27, 2007. Female patient, 55 years of age, was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: dementia, multiple sclerosis, nosocomial infection, pneumonia. COPAXONE dosage: unknown. Patient was hospitalized. Patient died.
Copaxone Side Effects Report #5290661-X
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on Mar 27, 2007. Female patient, 26 years of age, was diagnosed with depression, multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: abasia, dizziness, erythema, fear, feeling hot, flushing, nausea, oedema peripheral, pruritus. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5290665-7
Consumer or non-health professional from GERMANY reported COPAXONE problem on Mar 18, 2007. Male patient, 71 years of age, was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5291495-2
COPAXONE problem was reported by a Physician from UNITED STATES on Mar 29, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: benign peritoneal neoplasm. COPAXONE dosage: (20 MG), SUBCUTANEOUS. During the same period patient was treated with VALSARTAN, ATORVASTATIN CALCIUM, KARVEA HCT, METFORMIN, ACETYLSALICYLIC ACID SRT. Patient recovered.
Copaxone Side Effects Report #5292681-8
Pharmacist from UNITED STATES reported COPAXONE problem on Mar 30, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: sarcoidosis. COPAXONE dosage: 20 MG, SUBCUTANEOUS. During the same period patient was treated with VITAMIN CAP, FLUOXETINE HYDROCHLORIDE. Patient recovered.
Copaxone Side Effects Report #5292682-X
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 35 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5293981-8
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on Apr 03, 2007. Male patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: back pain, cardiac arrest. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5300836-9
COPAXONE problem was reported by a Health Professional from UNITED STATES on Apr 05, 2007. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, electroencephalogram abnormal, fear, hallucination, auditory, paranoia, persecutory delusion, poor personal hygiene, psychotic disorder, treatment noncompliance. COPAXONE dosage: (20 MG), SUBCUTANEOUS. During the same period patient was treated with LORAZEPAM, CARBAMAZEPINE, LOSARTAN POSTASSIUM, RISPERIDONE, BENZTROPINE MESYLATE, HALOPERIDOL, IBUPROFEN, ALUMINUM HYDROXIDE GEL. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5300843-6
Pharmacist from UNITED STATES reported COPAXONE problem on Apr 03, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, sarcoidosis. COPAXONE dosage: (20 MG), SUBCUTANEOUS. During the same period patient was treated with VITAMIN CAP, FLUOXETINE HYDROCHLORIDE. Patient recovered.
Copaxone Side Effects Report #5309209-6
COPAXONE problem was reported by a Health Professional from UNITED STATES on Apr 13, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: neoplasm. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5310979-1
Consumer or non-health professional from GERMANY reported COPAXONE problem on Apr 18, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, gait disturbance, hemiparesis. COPAXONE dosage: 20 MG (20 MG, 1 IN 1D); SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5259886-3
COPAXONE problem was reported by a Physician from UNITED STATES on Mar 01, 2007. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: diverticular perforation, peridiverticular abscess, peritoneal effusion. COPAXONE dosage: 20 MG, SUBCUTANEOUS. During the same period patient was treated with DYAZIDE, METOPROLOL SUCCINATE, ROFECOXIB, MODAFINIL, ALPRAZOLAM, LISINOPRIL, SERTRALINE, LOMOTIL. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5261704-4
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on Mar 05, 2007. Male patient was diagnosed with multiple sclerosis and was treated with COPAXONE. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient died.
Copaxone Side Effects Report #5261707-X
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Male patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: dehydration, multiple sclerosis. COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient died.
Copaxone Side Effects Report #5267039-8
Physician from UNITED STATES reported COPAXONE problem on Mar 05, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: benign peritoneal neoplasm. COPAXONE dosage: (20 MG), SUBCUTANEOUS. During the same period patient was treated with VALSARTAN, ATORVASTATIN CALCIUM, KARVEA HCT, METFORMIN, ACETYLSALICYLIC ACID SRT. Patient recovered.
Copaxone Side Effects Report #5269963-9
COPAXONE problem was reported by a Physician from IRELAND on Mar 08, 2007. Female patient was diagnosed with relapsing-remitting multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: atrioventricular septal defect, pregnancy, trisomy 21. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5273392-1
Consumer or non-health professional from SPAIN reported COPAXONE problem on Mar 07, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: raynaud's phenomenon. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5274627-1
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 29 years of age, was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: scleritis. COPAXONE dosage: unknown. Patient recovered.
Copaxone Side Effects Report #5274628-3
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on Mar 13, 2007. Female patient was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, intervertebral disc protrusion. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5274629-5
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: heart disease congenital, pregnancy, premature labour. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5275240-2
Consumer or non-health professional from GERMANY reported COPAXONE problem on Mar 06, 2007. Female patient, 49 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blister, ecchymosis, impaired healing, inflammation, injection site nodule, injection site pain, injection site pruritus, injection site swelling, injection site warmth. COPAXONE dosage: unknown. Patient recovered.
Copaxone Side Effects Report #5275242-6
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on Mar 13, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, hepatic cirrhosis, hepatotoxicity. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. During the same period patient was treated with ORAL CONTRACEPTIVE NOS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5277974-2
Consumer or non-health professional from GERMANY reported COPAXONE problem on Mar 13, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: pyogenic granuloma. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5277975-4
COPAXONE problem was reported by a Consumer or non-health professional from FRANCE on Mar 12, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: thrombocythaemia. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5277978-X
Consumer or non-health professional from GERMANY reported COPAXONE problem on Mar 14, 2007. Female patient, 26 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: dizziness, erythema, fear, feeling hot, flushing, nausea, pruritus, shock, speech disorder. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5281357-9
COPAXONE problem was reported by a Health Professional from UNITED STATES on Mar 23, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, urticaria. COPAXONE dosage: 20MG -PFS- DAILY SQ. Patient recovered.
Copaxone Side Effects Report #5284014-8
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on Mar 19, 2007. Female patient, 39 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, post procedural complication, respiratory arrest. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient recovered.
Copaxone Side Effects Report #5284213-5
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient died on 03/17/2007.
Copaxone Side Effects Report #5284844-2
Consumer or non-health professional from GERMANY reported COPAXONE problem on Mar 22, 2007. Female patient, 49 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blister, ecchymosis, impaired healing, inflammation, injection site nodule, injection site pain, injection site pruritus, injection site swelling, injection site warmth. COPAXONE dosage: 20 MG (20 MG, 1 IN 1D). Patient recovered.
Copaxone Side Effects Report #5286756-7
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on Mar 16, 2007. Female patient, 34 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: fibroma, leukoencephalomyelitis. COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Copaxone Side Effects Report #5286890-1
Physician from UNITED STATES reported COPAXONE problem on Mar 22, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. COPAXONE dosage: 20 MG, SUBCUTANEOUS. During the same period patient was treated with BACLOFEN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
< Previous Showing 301-397 of 397